U.S. Industrials Stock News

New Jersey Resources increased its quarterly dividend to $0.50 per share from $0.475, effective for the payment made on October 1, 2026, with shareowners of record as of September 24, 2026 receiving the higher payout. The new $2.00 per share annual dividend marked the 31st consecutive year of dividend growth, underscoring management’s emphasis on returning cash to investors alongside its regulated utility and clean energy investments. This article examines how New Jersey Resources'...

GameStop stock has delivered a steep 5 year decline of about 60%, yet current valuation checks flag a mixed picture rather than a simple verdict of cheap or expensive. The roughly 60% fall over five years means long term holders have seen significant value erode. This makes any hint of undervaluation feel tempting but also raises questions about how durable the underlying business model looks to the market. Stronger profitability tied to its large investment portfolio and tighter cost base...

Kroger (NYSE:KR) appointed Mark Ibbotson as Executive Vice President and Chief Store Operations Officer. Ibbotson previously led large scale store and omnichannel operations at Walmart and UK grocer Asda. His remit at Kroger covers store operations, grocery eCommerce and broader omnichannel transformation across the chain. Ibbotson's arrival in Kroger's top ranks is only one piece of how leadership shifts could reshape its store and eCommerce plans. Take a look at 4 warning signs we have...

CACI International reported quarterly revenue of $2.71b, up 17.6% year on year, with EBITDA and full-year EPS guidance both ahead of analyst estimates. The combination of rapid top-line expansion and stronger than expected profitability suggests CACI’s higher value technology contracts are scaling effectively across its federal customer base. We will now explore how CACI International’s strong revenue growth and upgraded EPS outlook could influence the longer term investment narrative. Scan...

Corning stock has delivered an extremely strong three year gain while the valuation checks send mixed messages, with the Discounted Cash Flow (DCF) pointing to a discount and market multiples suggesting the shares are not cheap. The result is a split picture on where intrinsic value sits after such a steep move. Corning has produced a roughly 4.5x total return over three years, which puts extra weight on whether recent pricing already bakes in much of the good news. The long term fiber...

Syndax Pharmaceuticals stock has delivered a 15.0% gain over the past year, yet current valuation checks suggest the shares lean expensive on traditional market multiples and only offer a mixed picture on value overall. For anyone tracking biopharma reratings, the key issue is whether that performance still leaves enough room for a return that fairly compensates for the clinical and funding risks ahead. Over the last 12 months, Syndax Pharmaceuticals has gained 15.0%, which puts recent...

Carnival (NYSE:CCL) has opened bookings for its newest Excel class ship, Carnival Tropicale, which is scheduled to sail from Galveston in 2028. The cruise line is promoting newly designed family-focused attractions on Carnival Tropicale, aimed at multigenerational travelers and group trips. Carnival Tropicale itineraries are billed as exclusive routes, giving early bookers access to sailings that were not previously available from Galveston. The early booking launch for Carnival Tropicale...

Arista Networks (NYSE: ANET) gained campus switch revenue share in the latest Dell'Oro Group report despite industry supply constraints. The research firm cited switch refresh cycles, public cloud demand and security-focused deployments as key drivers for campus switch spending. Vendors, including Arista, lifted average selling prices for campus switches while working through ongoing component shortages and extended lead times. Arista's campus switch share gains, along with higher pricing...

Arthur J. Gallagher (NYSE:AJG) has hired Steve Munday as managing partner of Natural Resources, focusing on renewables and energy transition. Munday previously led the global renewable practice at WTW and brings decades of sector experience to Gallagher. The move signals Gallagher's push to deepen its capabilities in renewables, clean energy and project finance-focused risk solutions. Steve Munday's appointment to lead Natural Resources is a meaningful move that investors should weigh...

Manulife’s principal operating insurer increased its institutional position in SELLAS Life Sciences during the second quarter, while SELLAS reported that its Phase 3 Regal trial had reached 78 of the 80 events needed for final analysis. This combination of a larger stake from a major insurer and an approaching Phase 3 data readout highlights how SELLAS Life Sciences is moving through a capital intensive phase in which clinical outcomes and funding access closely intersect. We will look at...

Penguin Solutions has surged year to date, yet its current checks point to a stock that looks roughly in line with an intrinsic value estimate while earnings multiples still hint at a discount. The share price has climbed 139.7% year to date, which puts extra focus on whether the recent rerating has already absorbed much of the upside. Fresh attention around its role in Lektra's distributed AI data centers can support longer term cash flow expectations, while any slowdown in AI...

Realta Fusion Inc. previously announced a partnership with Madison Gas and Electric and parent MGE Energy to explore a 200-megawatt fusion power plant in Wisconsin, alongside an equity stake and broad technical, siting, and financing support from the utility group. The agreement ties MGE Energy directly into Realta’s fusion research hub at OM Station, linking potential future generation capacity with activity already inside MGE’s service territory. This analysis examines how MGE Energy’s...

Vistra (VST) has filed an omnibus shelf registration for common and preferred stock, giving the utility additional flexibility to raise equity capital as it weighs funding options amid its current share price slide. Recent trading tells a mixed story for Vistra. The share price is down 2.68% on the day at US$147.05 and has declined 11.00% year to date, while the 1-year total shareholder return has fallen 27.56% after a very large 5-year total shareholder return of roughly 8x. In the short...

BioNTech stock has given up much of its early Covid-era surge, with the share price declining about 73.9% over the past five years. Yet the current market still prices the business at levels that screen as expensive on broad valuation checks. For investors, the puzzle is whether a stock that has already retreated this far now offers value, or whether the current tag still asks too much of future performance. Over five years, the share price has fallen about 73.9%, which signals that the...

Darling Ingredients has had a powerful share price run over the past year, yet valuation checks still lean on the cheap side. This puts the recent rally and the current pricing view directly against each other in investors’ minds. The stock has returned 107.9% over the past year. This means anyone looking at Darling Ingredients today is dealing with a very different entry point than twelve months ago. Expectations for the business to keep converting its feedstock and processing operations...

Six Flags Entertainment introduced Flex Pay by Upgrade in September 2026, letting eligible guests buy Season Passes and other products of US$49 or more online and pay over time through fixed monthly installments, with immediate access to pass benefits after activation and no prepayment penalties. This financing option could influence how visitors budget for trips, with more spending potentially shifting toward recurring passes and planned visits rather than one off ticket purchases. This...

GoDaddy (GDDY) has come into focus after recent share price swings, with the stock closing at US$96.37. Investors are weighing its one-month and three-month returns against its longer term performance. Recent swings sit against a mixed backdrop for GoDaddy. The 1-day share price return of 2.96% follows a 7-day share price decline of 7.01%. The 1-year total shareholder return is down 35.14%, while the 3-year total shareholder return is up 28.03%. Compare how GoDaddy stacks up against other...

Thermo Fisher Scientific (NYSE:TMO) is highlighted as a key supplier to organoid intelligence and brain organoid research tools. The company is also cited as a major equipment and consumables provider across multiomics workflows, including spatial omics platforms. Organoid intelligence and multiomics are gaining attention for roles in advanced research, precision medicine, and biological computing applications. This focus on Thermo Fisher's role in organoid intelligence and multiomics only...

MarineMax (HZO) has drawn fresh attention after its share price hovered near US$52.20, with recent returns over the past 3 months and year putting the stock back on many boating retail watchlists. MarineMax’s recent share price return has cooled in the very short term, yet the 90 day share price return of 53.53% and year to date share price return of 116.78% point to strong momentum, broadly echoed by a 1 year total shareholder return of 95.58%. Scan beyond MarineMax and see which retailers...

UDR stock presents a tricky valuation puzzle. The Discounted Cash Flow (DCF) intrinsic value estimate points to a meaningful gap versus the current share price, while market multiples suggest the opposite and recent returns over several years have been weak. Over the past 5 years, UDR has delivered a total return that declined 20.4%, which raises questions about how much of the business quality is already reflected in the current valuation. Future cash flow from its rental portfolio can...

Regeneron Pharmaceuticals (NasdaqGS: REGN) and certain officers face a new securities class action tied to the Phase III Fianlimab-Libtayo study. Filed investors allege the business issued materially false or misleading statements about the trial's statistical assumptions and clinical differentiation. The complaint claims Regeneron did not disclose key issues with the Phase III design that could affect interpretation of the Fianlimab-Libtayo data. This new class action over Fianlimab-Libtayo...

Gentherm (THRM) has drawn fresh attention after recent trading left the stock around $38.33, with short term returns turning negative while longer horizons still show positive total performance for patient shareholders. Recent trading has cooled, with the share price down 5.8% over the past week and about 7.4% over the last month. However, Gentherm still shows a positive 90 day share price return and a 1 year total shareholder return of 10.1%, suggesting earlier momentum has eased rather than...

Intellia Therapeutics (NasdaqGM:NTLA) said the FDA has accepted its Biologics License Application for lonvo-z for hereditary angioedema. The agency granted lonvo-z Priority Review, which signals an accelerated assessment timeline compared with a standard review process. If the BLA is approved, lonvo-z would become the first in vivo CRISPR-based therapy and a one-time treatment option for hereditary angioedema. The FDA’s Priority Review for lonvo-z is important, but investors should weigh it...

Without a fresh headline to point to, Haemonetics (HAE) is still drawing attention after a strong past 3 months and year. Investors are weighing recent share performance against fundamentals and valuation. At a share price of US$101.06, Haemonetics has slipped over the past week but still carries a 30-day share price return of 15.87% and a 90-day move of 29.23%. The 1-year total shareholder return of 88.97% signals strong positive momentum that investors are now weighing against the current...